Admera Health to explore strategic alternatives for pharmacogenomics and clinical services business (Admera Health)
"Admera Health...announced today that it has engaged Back Bay Life Science Advisors...to explore strategic alternatives for its pharmacogenomics and clinical services business as part of a company-wide strategic review. Admera offers the most comprehensive clinical PGx test in the industry, covering 62 genes, over 270 medications, and over 20 therapeutic areas, including:...oncology. Admera Health’s clinical services portfolio is built on a strong foundation of next-generation sequencing (NGS) and data analysis capabilities...OncoGxOne™...The product compliments Admera Health’s suite of NGS tests, spanning the continuum of cancer patient care."